|
Should government funding for the US National Institutes of Health be exempted
from federal budget sequestration cuts, debt ceiling negotiations and future
government shutdowns?
| Yes |
71% |
| No |
29% |
 |
|
|
|
|
|
|
|
22 October, 2013
|
|
|
Pharm Exec’s Annual Industry Audit — Who’s This Year’s Winner?
Pharm Exec’s annual Industry Audit holds charts the highs and lows of performance among 24 of the largest publicly traded companies during the last two years. We focus on a number of metrics to assess performance — including sales growth, gross margins and sales to employees — before announcing this year’s winner ...Read more |
Who Dares to Stop the European Transparency Bandwagon?
The research-based industry in Europe is moving out of the way the unstoppable
transparency juggernaut, hoping at best to nudge it into a less damaging direction as it roars past. But two companies are resisting the trend and have stepped straight into its path, shouting: “Stop!” ... Read more
|
Does IP Stimulate Growth and Create Jobs?
Yes, according to a new European Commission study on the impact Intellectual Property Rights have on GDP, employment, wages, and trade in the EU ... Read more
|
Market Access is Dead
Patient access is the new driver of change and progress in healthcare marketing, says a senior industry player in market development ... Read more
|
|
| Sciformix |
 Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations.  Read more. |
|
|
|
|
|
|
|
|
